|
Novavax News is an EIN News Service for health professionals. Constantly updated news and information about health.
- Vaccine system remains antiquated 24 Nov 2009 06:06 GMT
... against using adjuvants because the Food and Drug Administration has not fully reviewed them. Officials worried ... process dependent on chickens would be vulnerable. Pharmaceutical companies, however, have had little incentive to ... it worked in children and was safe. Novavax of Rockville is testing a similar vaccine ...
- Six Indian cos, CII ink deals to enhance cooperation 24 Nov 2009 11:32 GMT
... up with HCL Security Ltd to collaborate on delivering safety and security solutions. Cadila Pharmaceuticals and Novavax Inc joined hands to support production of key vaccines in India, including the recently developed H1N1 Pandemic Vaccine, Trivalent Seasonal Influenza Vaccine. "Apollo ...
- Six Indian cos, CII ink deals in US 24 Nov 2009 11:33 GMT
... up with HCL Security Ltd to collaborate on delivering safety and security solutions. Cadila Pharmaceuticals and Novavax Inc joined hands to support production of key vaccines in India, including the recently developed H1N1 Pandemic Vaccine, Trivalent Seasonal Influenza Vaccine. "Apollo ...
- 6 Indian cos, CII ink trade deals in US 24 Nov 2009 11:55 GMT
... HCL [ ] Security Ltd to collaborate on delivering safety and security solutions. Cadila Pharmaceuticals and Novavax Inc joined hands to support production of key vaccines in India [ ], including the recently developed H1N1 Pandemic Vaccine, Trivalent Seasonal Influenza ...
- 6 Indian cos, CII ink trade... 24 Nov 2009 13:17 GMT
... HCL [ ] Security Ltd to collaborate on delivering safety and security solutions. Cadila Pharmaceuticals and Novavax Inc joined hands to support production of key vaccines in India [ ], including the recently developed H1N1 Pandemic Vaccine, Trivalent Seasonal Influenza ...
- Indian industry associations sign economic pacts with US firms 24 Nov 2009 00:16 GMT
... help in use of their technologies. Cadila Pharmaceuticals Limited and Novavax Inc. joined hands with the vision to enable ... vision to enable the production of key vaccines in India, including the most recently developed ...
- Indian, US industry bodies ink dozen agreements, deepen economic ties 24 Nov 2009 05:31 GMT
... help in use of their technologies. Cadila Pharmaceuticals Limited and Novavax Inc. joined hands with the vision to enable ... the vision to enable production of key vaccines in India, including the most recently developed ...
- India-US to sign MoUs to boost economic cooperation 24 Nov 2009 06:10 GMT
... Tata Communications, Apollo, Jubiliant Organosys, Infosys, Cadila Pharmaceuticals and the Federation of Indian Chambers of ... Electronics, StemCyte, Univesity of Alabama, Microsoft Technologies, Novavax, University of Texas, Institute of International Education (IIE) ... collaboration in the fields of education, telecommunication, medicine and research and development (R&D). The US ...
- Stocks on the move: Consol, Dell, Leap, LogMeIn, Merck, Novavax 20 Nov 2009 18:12 GMT
... Average, adding 2.5 percent to $36.20. The drugmaker said the Committee for Medicinal Products for ... Agency recommended approval of Elonva as a treatment in controlled ovarian stimulation in combination with ... participating in an assisted reproductive technology program. Novavax Inc. (NVAX US) fell 11 percent to ...
- News and FDA Updates for Genta (OTC:GETA), POZEN (NASDAQ:POZN), Novavax (Nasdaq:NVAX) 21 Nov 2009 18:26 GMT
... FDA Updates for Genta (OTC:GETA), POZEN (NASDAQ:POZN), Novavax (Nasdaq:NVAX) BioMedReports.Com, the news portal which covers ... to the public of $3.30 per share. Biotech investors interested in seeing more details about ... flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made ...
- BiomedReports: News and FDA Updates for Genta (OTC:GETA), POZEN (NASDAQ:POZN), Novavax (Nasdaq:NVAX) 23 Nov 2009 12:34 GMT
... risk for associated gastric ulcers. On 11/20/09, Novavax, Inc. (Nasdaq:NVAX) announced it has priced an ... to the public of $3.30 per share. Biotech investors interested in seeing more details about ... flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made ...
- Drug developer Novavax to offer 6.8 million shares of common stock at $3.30 each; stock falls 20 Nov 2009 16:25 GMT
... ROCKVILLE, Md. (AP) - Biotech drug developer Novavax Inc. said Friday it plans to offer 6.8 million of its shares in an ...
- Novavax plans offering of 6.8M shares; stock falls 20 Nov 2009 16:25 GMT
... ROCKVILLE, Md. (AP) - Biotech drug developer Novavax Inc. said Friday it plans to offer 6.8 million of its shares in an ...
- Novavax Prices Public Offering of Common Stock 20 Nov 2009 14:50 GMT
... Novavax Prices Public Offering of Common Stock ROCKVILLE, Md., ... be used for preclinical studies and clinical trials of our VLP-based vaccines, internal research and ... such state or jurisdiction. is a clinical-stage biotechnology company, creating novel vaccines to address a ...
- Novavax Announces Public Offering of Common Stock 21 Nov 2009 04:30 GMT
... ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it intends ... such state or jurisdiction. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
nytimes.com:
ap.org:
bbc.co.uk:
reuters.com:
msnbc.msn.com:
healthday.com: